Scientific Opinion on the substantiation of health claims related to non characterised microorganisms pursuant to Article 13(1) of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 7, Issue 10, 2009, Pages

[No Author Info available]

Author keywords

Article 13; characterisation; health claims; Microorganisms; scientific substantiation; species; strain

Indexed keywords

EID: 82455177757     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2009.1247     Document Type: Article

References (69)

1. Adawi D, Kasravi B, Molin G, Jeppsson B, 1997. Effect of Lactobacillus supplementation With and Without Arginine on Liver Damage and Bacterial Translocation in an Acute Liver Injury Model in the Rat. Hepatology, 25, 642–647.
2. Altermann E, Russell WM, Azcarate-Peril MA, Barrangou R, Buck BL, McAuliffe O, Souther N, Dobson A, Duong T, Callanan M, Lick S, Hamrick A, Cano R, Klaenhammer TR, 2005. Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. PNAS, 102, 3906–3912.
3. Antonsson M and Molin G, 2002. Specific strains of Lactobacillus paracasei, used as adjunct in cheese production, survive the gastrointestinal tract and produce palatable cheese products. Patent WO2002018542.
4. BCCM/LMG Report 29/01/97. Identification of 3 bacterial isolates.
5. BCCM/LMG Report 04/09/98. Determination of carbohydrate fermentation pattern.
6. BCCM/LMG Report 04/02/99. Determination of carbohydrate fermentation pattern, SDS protein profiling.
7. Benedikt S, Van Hemel J, Vandenkerhove J, Peys E, Tan HM, Se C-Y, Ramchand CN, Varghese J, 2008. Use of bacillus amyloliquefaciens pb6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases. Patent application US20080057047.
8. Bianchi MA, del Rio D, Pellegrini N, Sansebastiano G, Neviani E, Brighenti F, 2004. A fluorescence-based method for the detection of adhesive properties of lactic acid bacteria to Caco-2 cells. Lett. Appl. Microbiol. 39, 301–305.
9. Bianchi-Salvadori B, Camaschella P, Bazzigaluppi E, 1984. Distribution and adherence of Lactobacillus bulgaricus in the gastroenteric tract of germ-animals. Milchwissenchaft. 39, 387–391.
10. Björneholm S, Eklöw A, Saarela M, Mättö J, 2002. Enumeration and identification of Lactobacillus paracasei subsp. paracasei F19. Microb. Ecol. Health Dis., 14(suppl. 3), 7–13.
11. Bonetti A, Morelli L, Campominosi E, 2002. Assessment of the persistence in the human intestinal tract of two probiotic lactobacilli Lactobacillus salivarius I 1794 and Lactobacillus paracasei I 1688. Microb. Ecol. Health. Dis., 14, 228–232.
12. Chandan RC, 1999. Enhancing market value of milk by adding cultures. J. Dairy. Sci., 82, 2245–2256.
13. Charteris WP, Kelly PM, Morelli L, Collins JK, 2001. Quality control Lactobacillus strains for use with the API 50CH and API ZYM systems at 37 degrees C. J. Basic Microbiol., 41, 241–251.
14. Collins JK and O'Mahony L, 2000. Testing the immunomodulatory (especially anti-inflammatory) effects of test materials by contacting with cells which interact with the immune system and cells of the immune system and determining changes in immunological markers. Patent WO200042429.
15. Cravero RA, 1996. New fermented milk product as liquid or powder - prepared by symbiotic culture of Lactobacillus casei and L. acidophilus, in milk substrate, has extended shelf life. Patent BR9501107.
16. Daniel C, Poiret S, Goudercourt D, Dennin V, Leyer G, Pot B, 2006. Selecting Lactic Acid Bacteria for Their Safety and Functionality by Use of a Mouse Colitis Model. Appl. Environ. Microbiol., 72, 5799–5805.
17. Ding WK and Shah NP, 2007. Acid, Bile, and Heat Tolerance of Free and Microencapsulated Probiotic Bacteria. J. Food. Sci., 72, M446–M450.
18. Dondi G and Morelli L, 1999. Treatment of lactobacilli cultures with inhibitory and/or microbicidal activity against pathogenic microorganisms. EP949330.
19. Dondi G, 2000. Selecting lactic bacteria (LB) for treating or preventing bacterial infections of the vagina and intestine, comprises incubating LB and pathogenic bacteria (PB) with human cells, then counting the number of adherent LB per human cell. EP1046713.
20. Drago L, de Vecchi E, Valli M, Nicola L, Lombardi A, Gismondo MR, 2002. Colonizzacione intestinale di Lactobacillus casei subsp. casei I-1572 CNCM (L. casei DG) in volontari sani e topi germ-free. Farmaci & Terapia. XIX(1/2):72–79.
21. Durand H and Panes J, 2001 Particles coated with a homogeneous, hydrophobic protective layer for use in pharmaceuticals, dietetic or feed compositions, comprise agglomerates of microorganisms. WO200168808.
22. Engel G, Rosch G, Heller KJ, 2003. Typification of bifidobacteria from fermented milk products with Pulsed Field Gel Electrophoresis (PFGE). Kieler. Milch. Forsch. 55, 225–232.
23. FAO/WHO (Food and Agriculture Organization / World Health Organization), 2006. Probiotics in food. Health and nutritional properties and guidelines for evaluation. FAO Food and Nutrition paper 85. FAO/WHO 2006. .
24. Felis GE and Dellaglio F, 2007. Taxonomy of Lactobacilli and Bifidobacteria. Curr. Issues Intestinal Microbiol., 8, 44–61.
25. Garrigues C, Stuer-Lauridsen B, Johansen E, 2005. Characterisation of Bifidobacterium animalis subsp. lactis BB-12 and other probiotic bacteria using genomics, transcriptomics and proteomics Aust. J. Dairy Technol., 60, 84–92.
26. Grahn EE and Holm SEF, 1990. Prophylaxis and/or treatment of beta-streptococcal tonsillitis - by using viable alpha-streptococcal strain which inhibits the beta-streptococci. Patent WO9009186.
27. Grahn Hakansson E and Ekbeck J, 2007. New microorganisms of the Lactobacillus strain comprising Lactobacillus plantarum LB3e or Lactobacillus plantarum LB7c, useful in manufacturing food products, e.g., bread or in promoting immunotolerance to autoimmune diseases. Patent WO2007108764.
28. Grahn Hakansson E, Roos K, Holm S, 1999. New pharmaceutical preparation, useful for prophylaxis and/or treatment of acute otitis media and middle otitis. WO9953932.
29. Gueimonde M, Delgado S, Mayo B, Ruas-Madiedo P, Margolles A, de los Reyes-Gavilan CG, 2004. Viability and diversity of probiotic Lactobacillus and Bifidobacterium populations included in commercial fermented milks. Food. Res. Int., 37, 839–850.
30. Hakansson EG, Forsgren-Brusk U, Anderson R, Holm SE, Hakansson S, 2004. New strain of Lactobacillus plantarum. Patent US 6761885.
31. Herve C, Fondrevez M, Cheron A, Barloy-Hubler F, Jan G, 2007. Transcarboxylase mRNA: A marker which evidences P. freudenreichii survival and metabolic activity during its transit in the human gut. Int. J. Food Microbiol., 113, 303–314.
32. IBSS Biomed Report. Laboratory test report on probiotic properties of Lactobacillus strains.
33. Jan G, Rouault A, Maubois J-L, 2000. Acid stress susceptibility and acid adaptation of Propionibacterium freudenreichii subsp. Shermanii. Lait, 80, 325–336.
34. Jan G, Leverrier P, Proudy I, Roland N, 2002. Survival and beneficial effects of propionibacteria in the human gut: in vivo and in vitro investigations. Lait, 82, 131–144.
35. Janoir et al. Unpublished. 16S, 16S-23S intergenic complete sequence and 23S partial sequence. Genbank accesion number AY370682.
36. Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, Zoetendal EG, de Vos WM, Vapaatalo H, Korpela R, 2008. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment. Pharmacol. Ther., 27, 48–57.
37. Ljungh-Wadstrom A, Wadstrom T, Bengmark S, 2004. Probiotic composition for treating gastrointestinal disturbances comprises at least two lactic acid bacterial strains. Patent WO2004103083.
38. Masco L, Ventura M, Zink R, Huys G, Swings J, 2004. Polyphasic taxonomic analysis of Bifidobacterium animalis and Bifidobacterium lactis reveals relatedness at the subspecies level: reclassification of Bifidobacterium animalis as Bifidobacterium animalis subsp. animalis subsp. nov. and Bifidobacterium lactis as Bifidobacterium animalis subsp. lactis subsp. nov. Int. J. Syst. Evol. Microbiol., 54, 1137–1143.
39. Mayer HK, Amtmann E, Philippi E, Steinegger G, Mayrhofer S, Kneifel W, 2007. Molecular discrimination of new isolates of Bifidobacterium animalis subsp. lactis from reference strains and commercial probiotic strains. Int. Dairy J., 17, 565–573.
40. Meile L, Ludwig W, Rueger U, Gut C, Kaufmann P, Dasen G, Wenger S, Teuber M, 1997. Bifidobacterium lactis sp. Nov., a moderately oxygen tolerant species isolated from fermented milk. Syst. Appl. Microbiol., 20, 57–64.
41. Mesnage P, Le Blan T, Griffouliere S, Courdesses S, 2007. Sticking cotton treatment method. US Patent application US20070214608.
42. Molin G, Jeppsson B, Johansson ML, Ahrné S, Nobaek S, Ståhl M, Bengmark S, 1993. Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines. J. Appl. Microbiol., 74, 314–323.
43. Molin G, Ahrne S, Jeppsson B, 2004. Composition for treating cardiovascular disease, diabetes, cancer, Alzheimer's disease, has tannase-producing strains of Lactobacillus plantarum or Lactobacillus species that adhere to human intestinal mucosa in combination with tannin. Patent WO2004087893.
44. Molin G, Ahrne S, Jeppsson B, Vasquez A, Berggren A. 2006. New Lactobacillus strains with the ability to colonize the human vagina, useful in probiotic food products, hygiene products, and pharmaceutical compositions for promoting vaginal health and preventing and treating vaginal infections. Patent WO2006038869.
45. Morelli, 1996. Identification of two strains of Lactobacillus for a patent deposit. Final Report.
46. Morelli, 1997. Microbiological analysis of 6 strains of Lactobacillus for a patent deposit. Final Report.
47. Nighswonger BD, Brashears MM, Gilliland SE, 1996. Viability of Lactobacillus acidophilus and Lactobacillus casei in fermented milk products during refrigerated storage. J. Dairy. Sci., 79, 212–219.
48. O'Riordan K, Fitzgerald GF, 1997. Determination of genetic diversity within the genus Bifidobacterium and estimation of chromosomal size. FEMS Microbiol. Letters, 156, 259–264.
49. Pedraglio G, 2004. New stable Lactobacillus strains selected culturing microbes, freeze-drying, rehydrating and incubation - used to treat gastrointestinal disorders e.g. diarrhoea, constipation, chronic intestinal inflammation, colitis and flatulence. Patent EP861905.
50. Peys E, Varghese J, Suresh P, Vandenkerckhove J, Van hemel J, Chaniyilparampu RN, Sas B, 2007. Effects of Bacillus subtilis ‘PB6’ (ATCC - PTA 6737) on Clostridium difficile Associated Diarrhea (CDAD) and Inflammatory Bowel Disease (IBD) in Animal Models. Am. J. Infect. Dis., 3, 254–265.
51. Rönnqvist D, Ström H, Forsgren-Brusk U, Grahn Hakanson E, 2005. Selection and characterization of a Lactobacillus plantarum strain promising as a urogenital probiotic. Microb. Ecol. Health. Dis., 17, 75–82.
52. Rönnqvist PDJ, Forsgren-Brusk UB, Grahn Hakanson EE, 2006. Lactobacilli in the female genital tract in relation to other genital microbes and vaginal pH. Acta Obstetric. Ginecol., 85, 726–735.
53. Sakata S, Kitahara M, Sakamoto M, Hayashi H, Fukuyama M, Benno Y, 2002. Unification of Bifidobacterium infantis and Bifidobacterium suis as Bifidobacterium longum. Int. J. Syst. Evol. Microbiol., 52, 1945–1951.
54. Sanders ME, Klaenhammer TR, 2001. Invited Review: The Scientific Basis of Lactobacillus acidophilus NCFM Functionality as a Probiotic. J Dairy Sci., 84, 319–331.
55. Sozzi T, 1989. Preparation of compositions including acid-resistant bifidobacteria. Patent US4870020.
56. Su P, Henriksson A, Mitchell H, 2007. Survival and retention of the probiotic Lactobacillus casei LAFTI_ L26 in the gastrointestinal tract of the mouse. Lett. Appl. Microbiol., 44, 120–125.
57. Sullivan A, Palmgren A.C, Nord CE, 2001. Effects of Lactobacillus paracasei on intestinal colonisation of lactobacilli, bifidobacteria and Clostridium difficile in elderly persons. Anaerobe, 7, 67–70.
58. Tabasco R, Paarup T, Janer C, Pelaez C, Requena T, 2007. Selective enumeration and identification of mixed cultures of Streptococcus thermophilus, Lactobacillus delbrueckii subsp. bulgaricus, L. acidophilus, L. paracasei subsp. paracasei and Bifidobacterium lactis in fermented milk. Int. Dairy J., 17, 1107–1114.
59. Tam NKM, Uyen NQ, Hong HA, Duc LH, Hoa TT, Serra CR, Henriques AO, Cutting SM, 2006. The intestinal life cycle of Bacillus subtilis and close relatives. J. Bacteriol., 188, 2692–2700.
60. Tano K, Olofsson C, Grahn-Håkansson E, Holm SE, 1999. In vitro inhibition of S. pneumoniae, nontypable H. influenzae and M. catharralis by alpha-hemolytic streptococci from healthy children. Int. J. Pediatr. Otorhynolar., 47, 49–56.
61. Teo AY-L and Tan H-M, 2005. Inhibition of Clostridium perfringens by a Novel Strain of Bacillus subtilis Isolated from the Gastrointestinal Tracts of Healthy Chickens. Appl. Environ. Microbiol., 71, 4185–4190.
62. Tynkkynen S, Satokari R, Saarela M, Mattila-Sandholm T, Saxelin M, 1999. Comparison of ribotyping, randomly amplified polymorphic DNA analysis, and pulsed-field gel electrophoresis in typing of Lactobacillus rhamnosus and L. casei strains. Appl. Environ. Microbiol., 65, 3908–3914.
63. Vankerckhoven V, Huys G, Vancanneyt M, Vael C, Klare I, Romond MB, Entenza JM, Moreillon P, Wind RD, Knol J, Wiertz E, Pot B, Vaughan EE, Kahlmeter G, Goossens H, 2008. Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project. Trends Food Sci. Tech., 19, 102–114.
64. Vasquez A, Ahrne S, Jeppsson B, Molin G, 2005a. Oral administration of Lactobacillus and Bifidobacterium strains of intestinal and vaginal origin to healthy human females: Re-isolation from faeces and vagina. Microb. Ecol. Health Dis., 17, 15–20.
65. Vasquez A, Molin G, Pettersson B, Antonsson M, Ahrne S, 2005b. DNA-based classification and sequence heterogeneities in the 16S rRNA genes of Lactobacillus casei/paracasei and related species. Syst. Appl. Microbiol., 28, 430–441.
66. Ventura M, Elli M, Reniero R, Zink R, 2001a. Molecular microbial analysis of Bifidobacterium isolates from diferent environments by the species-specific amplified ribosomal DNA restriction analysis (ARDRA). FEMS Microbiol. Ecol., 36, 113–121.
67. Ventura M, Reniero R, Zink R, 2001b. Specific identifications and targeted characterization of Bifidobacterium lactis from different environmental isolates by a combined multiplex-PCR approach. Appl. Environ. Microbiol. 67, 2760–2765.
68. Ventura M, Canchaya C, Meylan V, Klaenhammer TR, Zink R, 2003. Analysis, characterization, and loci of the tuf genes in Lactobacillus and Bifidobacterium species and their direct application for species identification. Appl. Environ. Microbiol. 69, 6908–6922.
69. Yimin et al. Unpublished. 16S rRNA complete sequence. Genbank accession number AB027536.